COMPASS Pathways Plc American Depository Shares (CMPS) Stock Price

CMPSStock
$14.88+208.03%52W
Market Cap$2.06B
P/E
PEG Ratio
Div yield
Beta2.57

CMPS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)56.80%
Price vs S&P 500 (4W)27.82%
VGM Score80.72

CMPS Earnings Surprise History

Q2 25-0.41est. -0.37
Q3 25-0.38est. -0.41
Q4 25-0.61est. -0.39
Q1 26-0.30est. -0.32
Q2 26-0.36est. -0.34

CMPS Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.15
4.23
4.26
4.25

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
CMPSCOMPASS Pathways Plc American Depository Shares
A$14.88
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About COMPASS Pathways Plc American Depository Shares

Compass Pathways is a mental health company developing psilocybin-based therapies for treatment-resistant depression (TRD), a severe form of major depressive disorder with limited existing treatment options. The company's approach combines its proprietary high-purity psilocybin formulation (COMP360) with psychological support to create a comprehensive treatment model. By targeting an underserved patient population, Compass addresses a significant unmet medical need in mental health care.